Sign up to save your podcasts
Or
Share Residual tumor volume and survival after CCNU/TMZ in GBM
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Residual tumor volume and survival after CCNU/TMZ in GBM
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
View all episodes
By Neuro-Oncology
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
More shows like Neuro-Oncology: The Podcast
View all
Planet Money
30,798 Listeners
Hidden Brain
43,647 Listeners
Global News Podcast
7,713 Listeners
The Gray Area with Sean Illing
10,714 Listeners
NEJM This Week
317 Listeners
Mayo Clinic Talks
298 Listeners
The Curbsiders Internal Medicine Podcast
3,347 Listeners
The Daily
112,451 Listeners
Up First from NPR
56,739 Listeners
Today, Explained
10,235 Listeners
The Peter Attia Drive
8,594 Listeners
Hard Fork
5,528 Listeners
The Ezra Klein Show
16,001 Listeners
New Heights with Jason & Travis Kelce
18,195 Listeners
Not Gonna Lie with Kylie Kelce
10,152 Listeners